Blast cells from a total of 1,971 patients with ALL were successfully studied for their karyotype. Of these patients, 602 were The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section I734 solely to indicate this fact. 
tetraploid cases have relapsed or died. This study suggests that the near-tetraploid subtype differs from other cases of hyperdiploid >50 ALL, which have been associated with a favorable prognosis. 0 1990 by The American Society of Hematology.
admitted to Total Therapy Studies X and XII6 at St Jude Children's Research Hospital (SJCRH; Memphis, TN) between 1981 and 1988, and 1,369 were enrolled in Pediatric Oncology Group (POG) studies 8602" and 8704" from 1986 to 1989. Bone marrow specimens from patients enrolled in the POG studies were shipped to the University of Alabama at Birmingham (UAB) for chromosome analysis and to SJCRH for flow cytometric studies. All patients were advised of the procedures and their attendant risks, in accord with institutional guidelines; informed consent was obtained in each instance.
Williams et
Samples from POG institutions other than SJCRH were placed in RPMI 1640 supplemented with 15% fetal calf serum and shipped overnight to the UAB cytogenetic laboratory. On arrival, samples were placed in short-term (24-hour) cult~re.~' Routine methods were used for culture harvest, slide preparation, and GTG-banding. Chromosome abnormalities were classified according to the International System for Human Cytogenetic Nomenclat~re.'~
DNA Content Determination
Leukemic marrow samples were stained with a DNA-specific dye, propidium iodide, and analyzed by flow cytometry, as previously de~cribed.,~ Results were expressed as the DNA index (ratio of DNA content in leukemic Go/G, cells to that in normal diploid G,/G, cells), a measure that correlates closely with chromosome number. Multiple leukemic lines within a single case were arbitrarily designated first and second, based on DNA content per cell (lowest content = first line). The percentages of cells in the Go/G,, S, and G, + M phases were determined by analyses using the computer program PEAK.26 In cases with two leukemic lines, the percentage of S phase was determined for the higher ploidy line.
Statistical Analysis
Differences in the distribution of clinical and biologic features between near-tetraploid cases and those with other ploidies were tested by the two-tailed Fisher exact test or the Pearson chi-square test for categorical variables, and by the Wilcoxon test for continuous variables. Correlation between the percentages of large blasts and of blast cells in S phase among near-tetraploid cases was tested by the Spearman rank-order analysis.
RESULTS
Of the 1,97 1 cases studied, 26 (1.3%) were found to have a leukemic stem line with greater than 65 chromosomes by karyotypic analysis or flow cytometry. In three of the 24 cases in which hyperdiploidy >65 was identified by chromosome analysis, flow cytometry was not performed (see Table  1 ). There were two cases in which the near-tetraploid line was detected by flow cytometric analysis, but karyotypic study showed only residual normal cell metaphases. Among the remaining 21 cases, the DNA index and the karyotype ploidy determination were closely correlated.
For comparison of cytogenetic and clinical features, the 26 cases were divided into two subgroups: near-triploid (66 to 73 chromosomes, cases 1 through 6) and near-tetraploid (82 to 94 chromosomes, cases 7 through 26).
Karyotypic Findings
The modal chromosome number of the leukemic cell lines in these six cases ranged from 66 to 73. One case (no. 3) had two abnormal leukemic lines detected by flow cytometric analysis. Structural chromosomal abnormalities were noted in 4 of the 6 cases. Every chromosome was involved in trisomies, and some in tetrasomies (numbers 8, 10, 11, 14, 18, 21, and sex chromosomes). Five copies of chromosome 21 were found in two cases and six copies in another case.
The modal chromosome num- 
Morphologic Findings
Bone marrow slides were adequate for review in 5 of the 6 near-triploid cases. Four of these five cases had cleaved nuclei with clumped chromatin and two had vacuolated cytoplasm; only one had L2 morphology, and none contained more than 50% large blast cells (Table 2) .
Among the 20 near-tetraploid cases, cleaved nuclei were noted in 17 cases, clumped chromatin in 16, vacuolated cytoplasm in 6, L2 morphology in 6, and greater than 50% large blasts in 4. The typical findings of cleaved nucleus with clumped chromatin are depicted in Figs 1 and 2 . The frequency of L2 morphology in the near-tetraploid cases was significantly higher than that in other ploidy groups (30% v 22%, P < .01). The L2 blasts were characterized by low nuc1ear:cytoplasmic ratio and irregular nuclear shape in all 6 cases, large cell size in 3, and prominent nucleoli in 2. As expected, L2 cases had significantly higher percentages of large blasts than L1 cases (median, 52.5% v 13.5%, P = .02). The percentages of blast cells in S phase did not differ significantly between the L1 and L2 cases (median, 7.3% v 12.7%, P = .23); however, the percentage of S phase was determined in only three L2 cases. There was also no correlation between the percentages of large blasts and the proportion of blasts in S phase in the near-tetraploid cases (n = 17, r = .2, P = .43).
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Clinical Characteristics and Treatment Outcome
The three boys and three girls ranged in age from 2.0 to 11.2 years a t diagnosis (median, 4.5 years). Leukocyte counts ranged from 3 to 38 x 109/L (median, 11.5 x 109/L); platelet counts from 49 to 320 x 109/L (median, 144 x 109/L); and hemoglobin levels from 6.3 to 11 g/dL (median, 7.5 g/dL). None of these patients had a mediastinal mass or central nervous system (CNS) leukemia at diagnosis. Early pre-B and pre-B ALL were each found in three cases. None of the five cases tested (nos. 1 to 5 ) expressed myeloid-associated antigens. All six patients remain in continuous complete remission from 1 + to 3 1 + months. The number of near-triploid cases was too small for meaningful statistical comparisons with cases of other ploidies.
The 12 male and 8 female patients ranged in age from 2.8 to 19.2 years (median, 8.6
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Near-tetraploid subgroup. were classified as T-cell (CDl-/CD3-, CDl+/CD3-, and CD3+ in 3 cases each); 5 as pre-B; and 5 as early pre-B-ALL. This frequency of T-cell ALL was significantly higher than that found in the patients with other ploidies (47% v 14%, P < .001). Five cases (nos. 10, 12, 14, 15, and 24) were not tested for myeloid-associated antigen expression. Of the 15 cases tested, 6 expressed one or two myeloid-associated markers:case8, CD15;case 11,CD33;case 16,CD13/CD15; case 19, CD13/CD33; case 22, CD15; and case 23, CD33. Six patients have relapsed or died; five of these had T-cell ALL. Most of the patients who remain in remission have been followed for less than 2 years.
DISCUSSION
The 1.0% frequency of near-tetraploidy in this series substantiates the rarity of this chromosomal abnormality in childhood ALL. Even fewer cases would have been detected had karyotypic analysis been used alone. The Third International Workshop on Chromosomes in Leukemia reported only one near-tetraploid case among 330 banded cases of childhood and adult ALL.27 Heerema et all3 found one near-tetraploid case in their study of 70 newly diagnosed children with ALL. In our earlier study of 519 newly diagnosed childhood ALL cases with banded leukemia cell chromosomes, four cases (0.8%) were near-tetraploid. ' Near-tetraploid cases in this study were significantly more likely to have a T-cell immunophenotype (47%), and L2 morphology (30%), and to be older at diagnosis (median age, 8.6 years) than the cases with other ploidies. Similarly, of the six cases of near-tetraploid childhood leukemia previously reported by other investigators, the median age at diagnosis was 11 years, three cases had T-cell ALL, and three had L2 morphol~gy.'~'~*'~ Despite contemporary intensive therapy, 6 of our 20 patients have relapsed or died, further, the follow-up for most of the patients who remain in remission is short. These differences are particularly striking in comparison with cases of hyperdiploidy >SO, which account for approximately one fourth of children with newly diagnosed ALL. The median age of these cases at diagnosis is 3.6 years, only 3% have a T-cell immunophenotype, and 10% have L2 morphology.' More importantly, hyperdiploid >SO cases have a favorable prognosis: at least two thirds will become long-term survivors with contemporary treatment.8*2'*29 Thus, near-tetraploid ALL should be regarded as a distinct entity from other hyperdiploid >SO cases.
Near-tetraploid cases appeared to have a high frequency of myeloid-associated antigen expression. Six of the 15 cases tested expressed one or more of three myeloid-associated antigens CD13, CDl5, and CD33. In our earlier study of 372 childhood ALL cases with a comprehensive panel of myeloidassociated MoAbs representing seven cluster groups, 6 1 cases ( 16.4%) expressed myeloid-associated antigen(s) and 31 (8.3%) expressed CD13, CD15, or CD33." In that study, myeloid-associated antigen expression had no effect on treatment outcome in the context of intensive chemotherapy. Of the six near-tetraploid cases described here with myeloidassociated antigen expression, one did not achieve remission and one has relapsed, with relatively short follow-up. Additional studies are needed to determine the prognosis of this subgroup of patients.
Near-triploidy is an even rarer finding in childhood ALL. We are aware of only one reported case in a child; this patient had the Philadelphia chromosome and a T-cell phen~type.'~ In the present study, only 6 of 1,971 children (0.3%) with newly diagnosed ALL had a near-triploid leukemic cell line. The initial clinical features of these patients did not appear to differ substantially from those of reported hyperdiploid >SO cases,' and all six patients remain in continuous complete remission. However, 3 of the 6 near-triploid cases had a pre-B immunophenotype, which was observed in only 16% of our previously reported hyperdiploid >50 ALL cases.' Further, only 13 of 70 children with pre-B-ALL had blast cell hyperdiploidy > 50.2' Thus, the clinical and biologic relationship of near-triploid cases to other hyperdiploid >50 cases remains unclear.
Large blast cells have been described in five cases of near-tetraploid l e~k e m i a . '~.~' .~~ In our study, the presence of large blast cells or large nuclei was not a prominent feature of near-tetraploid cases; only 4 of the 20 patients had greater than 50% large blasts detected in bone marrow smears. This is not surprising because the volume of a nucleus can be doubled by a 1.26-fold increase in diameter, a difference that may not be appreciable visually. Moreover, the size of nuclei depends on many factors in addition to the DNA content. For example, the diploid nuclei are larger in myeloblasts than in lymphoblasts, and L2 lymphoblasts are larger than L1 blasts. Indeed, of the five previously reported near-tetraploid cases with large blast cells, four had acute nonlymphoblastic leukemia and the fifth had L2 ALL.'293'q32 Characteristic features in our near-triploid and near-tetraploid cases (clumping of the chromatin with cleaving of the nucleus) may represent an attempt of lymphoblasts to accommodate the extra DNA.
Endoreduplication of a cell in the diploid range, with or without subsequent gain or loss of chromosomes, appears to be the most feasible mechanism to account for neartetraploidy, although fusion of two different diploid cells has also been ~uggested.~' The most compelling evidence for the former explanation is the presence of paired chromosomes containing the same rearrangements or deletions in 6 of our 9 near-tetraploid cases with structural abnormalities. Detailed analyses were unsuccessful in the remaining cases because chromosomes were fuzzy and insufficiently spread, a problem also encountered by other investigator^.^^.'^ Several mechanisms have been proposed for the development of neartriploidy, including nondisjunction, duplication of hypodiploid cells, loss of chromosomes from tetraploid cells, and multipolar mitosis of tetraploid cells.I4 The absence of a hypodiploid line or paired marker chromosomes in our cases suggests that nondisjunction is the most likely cause.
Results of flow cytometric determination of cellular DNA content and conventional cytogenetic analysis of ploidy were closely correlated in this study. DNA content can be determined by flow cytometry for virtually all cases because the measurements are not affected by the mitotic index of the cell population. However, flow cytometry does not identify the specific chromosomal changes, which may have important prognostic and biologic implications. Thus, the two tests should be used in tandem in studying patients with leukemia. Cases identified as having near-tetraploid stem lines by either method should be categorized separately from the prognostically favorable hyperdiploid >50 group. Whether near-triploid cases are clinically and prognostically distinct from those with hyperdiploidy >50 requires further study.
